首页|不同范围的INR对应用华法林的老年患者的影响

不同范围的INR对应用华法林的老年患者的影响

扫码查看
目的:探究不同范围的INR对应用华法林的老年患者的影响,及其临床疗效及其安全性。方法:选取 2019年1月—2020年 12月我院内科住院治疗的 100例老年非瓣膜病房颤患者为研究对象,随机分为对照组和研究组,各 50例。对照组INR维持在 1。6~2。0,研究组INR维持在 2。1~2。6,根据INR值调整华法林剂量。各组INR达到目标值前每周监测 1次INR。INR稳定后每 4周监测 1次。观察比较 2组临床疗效及出血栓塞等不良事件发生率。结果:2组出血发生情况比较,差异无统计学意义(P>0。05);研究组不良事件发生率、NT-proBNP水平均低于对照组,组间差异有统计学意义(P<0。05)。结论:INR控制在 2。1~2。6时,在预防老年人非瓣膜性房颤临床栓塞等不良事件的发生,保护血管内皮预防血栓形成的同时,可进一步改善患者心功能。
Effects of Different Ranges of INR on Elderly Patients Receiving Warfarin
Objective:To explore the effects of different ranges of INR on elderly patients treated with warfarin,its clinical efficacy and safety.Methods:100 elderly patients with nonvalvular atrial fibrillation hospitalized in our hospital from January 2019 to December 2020 were selected as the study objects and randomly divided into a control group and a study group,with 50 cases in each group.The INR of the control group was maintained at 1.6~2.0,and the INR of the study group was maintained at 2.1~2.6.The warfarin dose was adjusted according to the INR value.The INR of each group was monitored once a week before reaching the target value.The INR was monitored every 4 weeks after stabilization.The clinical efficacy and incidence of adverse events such as bleeding embolization were observed and compared between the two groups.Results:There was no significant difference in the occurrence of hemorrhage between the two groups(P>0.05).The incidence of adverse events and the level of NT-proBNP in the study group were significantly lower than those in the control group(P<0.05).Conclusion:When INR is controlled in the range of 2.1~2.6,it can prevent clinical embolism and other adverse events in elderly patients with NVAF,protect vascular endothelium to prevent thrombosis,and further improve the cardiac function of patients.

INRDifferent rangesWarfarinElderly patientsCardiac function

赵玉红、李艳、陆华岭、颜蕾、史嘉炜、宁思思、陈剑锋、郁惠英

展开 >

上海市长宁区天山中医医院内科,上海 200051

上海市长宁区天山中医医院科教科

上海市长宁区天山中医医院医务科

上海国际医学中心

上海市松江区泗泾医院

展开 >

INR 不同范围 华法林 老年患者 心功能

2024

中国伤残医学
中国康复医学会,黑龙江省截瘫研究所

中国伤残医学

影响因子:0.451
ISSN:1673-6567
年,卷(期):2024.32(12)